Michael Wiederhorn

Stock Analyst at Oppenheimer

(3.34)
# 1,012
Out of 4,913 analysts
141
Total ratings
49.64%
Success rate
2.11%
Average return

Stocks Rated by Michael Wiederhorn

Centene
Jul 15, 2025
Maintains: Outperform
Price Target: $85$51
Current: $27.73
Upside: +83.95%
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600$400
Current: $282.80
Upside: +41.44%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300$310
Current: $236.25
Upside: +31.22%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400$375
Current: $294.97
Upside: +27.13%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14$12
Current: $8.24
Upside: +45.72%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34$37
Current: $23.32
Upside: +58.70%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390$400
Current: $335.66
Upside: +19.17%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165$168
Current: $150.11
Upside: +11.92%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140$145
Current: $109.07
Upside: +32.95%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32$40
Current: $11.64
Upside: +243.64%
Maintains: Outperform
Price Target: $4.5$5
Current: $2.66
Upside: +88.32%
Maintains: Perform
Price Target: n/a
Current: $6.73
Upside: -
Maintains: Outperform
Price Target: $625$650
Current: $468.36
Upside: +38.78%
Maintains: Outperform
Price Target: $175$145
Current: $97.83
Upside: +48.22%